Vyant Bio VYNT Stock
0 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
0 USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Vyant Bio Price Chart
Vyant Bio VYNT Financial and Trading Overview
| Vyant Bio stock price | USD |
| Previous Close | 0.23 USD |
| Open | 0.23 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1800 |
| Day's Range | 0.23 - 0.23 USD |
| 52 Week Range | 0.2 - 4.94 USD |
| Volume | 516 USD |
| Avg. Volume | 177.21K USD |
| Market Cap | 1.43M USD |
| Beta (5Y Monthly) | 0.449376 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5 USD |
VYNT Valuation Measures
| Enterprise Value | -6415962 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.104109585 |
| PEG Ratio (5 yr expected) | 0 |
| Price/Sales (ttm) | 2.1457012 |
| Price/Book (mrq) | 0.13628213 |
| Enterprise Value/Revenue | -9.634 |
| Enterprise Value/EBITDA | 0.417 |
Trading Information
Vyant Bio Stock Price History
| Beta (5Y Monthly) | 0.449376 |
| 52-Week Change | -94.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.94 USD |
| 52 Week Low | 0.2 USD |
| 50-Day Moving Average | 0.33 USD |
| 200-Day Moving Average | 1.13 USD |
VYNT Share Statistics
| Avg. Volume (3 month) | 177.21K USD |
| Avg. Daily Volume (10-Days) | 6.55K USD |
| Shares Outstanding | 5.91M |
| Float | 5.11M |
| Short Ratio | 1.8 |
| % Held by Insiders | 18.94% |
| % Held by Institutions | 5.82% |
| Shares Short | 204.71K |
| Short % of Float | 3.54% |
| Short % of Shares Outstanding | 3.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2389.18% |
| Gross Margin | -51.35% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.64% |
| Return on Equity (ttm) | -76.73% |
Income Statement
| Revenue (ttm) | 666K USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | -87.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -15390000 USD |
| Net Income Avi to Common (ttm) | -15807000 USD |
| Diluted EPS (ttm) | -2.92 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.04M USD |
| Total Cash Per Share (mrq) | 1.6 USD |
| Total Debt (mrq) | 2.2M USD |
| Total Debt/Equity (mrq) | 22.16 USD |
| Current Ratio (mrq) | 3.14 |
| Book Value Per Share (mrq) | 1.673 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13681000 USD |
| Levered Free Cash Flow (ttm) | -9395000 USD |
Profile of Vyant Bio
| Country | United States |
| State | NJ |
| City | Cherry Hill |
| Address | 2 Executive Campus |
| ZIP | 08002 |
| Phone | 201 479 1357 |
| Website | https://www.vyantbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.
Q&A For Vyant Bio Stock
What is a current VYNT stock price?
Vyant Bio VYNT stock price today per share is USD.
How to purchase Vyant Bio stock?
You can buy VYNT shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vyant Bio?
The stock symbol or ticker of Vyant Bio is VYNT.
Which industry does the Vyant Bio company belong to?
The Vyant Bio industry is Biotechnology.
How many shares does Vyant Bio have in circulation?
The max supply of Vyant Bio shares is 0.
What is Vyant Bio Price to Earnings Ratio (PE Ratio)?
Vyant Bio PE Ratio is 0.00000000 now.
What was Vyant Bio earnings per share over the trailing 12 months (TTM)?
Vyant Bio EPS is 0 USD over the trailing 12 months.
Which sector does the Vyant Bio company belong to?
The Vyant Bio sector is Healthcare.
Vyant Bio VYNT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17601.05 USD — |
+0.87
|
8.38B USD — | 17181.27 USD — | 17716.52 USD — | — - | 8.38B USD — |
| NASDAQ HealthCare IXHC | 942.47 USD — |
+1.43
|
— — | 920.56 USD — | 943.62 USD — | — - | — — |
- {{ link.label }} {{link}}